Clinical Trial Update: Vitamin D in OUD: Exploration of Alterations on the Dopamine D2/D3 Receptor System [Phase 1]

View source ↗

Summary

A Phase 1 trial conducted at Yale University completed, evaluating how Vitamin D relates to alterations in the dopamine D2/D3 receptor system in individuals wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Vitamin D (Cholecalciferol)

Snippet

Sponsor: Yale University | Conditions: Opioid Use Disorder | Phase 1 | Status: COMPLETED